Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 892

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 892
---
 and made between, amongst others, OmnigenicsAI, the Surviving Company and the Merging Company in the form annexed at Annexure 1 hereto as may be amended from time to time (the “ Business Combination Agreement”). 4.2From the Effective Date, the rights and restrictions attaching to the shares of the Surviving Company are set out in the M&A (as defined below). 5Memorandum and articles of the Surviving Company 5.1The Memorandum and Articles of Association of the Surviving Company shall be amended and restated by the deletion in their entirety and the substitution in their place of the Amended and Restated Memorandum and Articles of Association in the form annexed at Annexure 2 hereto on the Effective Date, and the authorised share capital of the Surviving Company shall be as set out therein. 5.2Upon the Effective Date, the authorised share capital of the Surviving Company shall be increased from US$22,100 divided into 200,000,000 Class A ordinary shares of a par value of US$0.0001 each, 20,000,000 Class B ordinary shares of a par value of US$0.0001 each and 1,000,000 preference shares of a par value of US$0.0001 each to US$50,000 divided into 50,000 Shares each of a par value of US$1.00 each by the cancellation of (i) 20,000,000 Class B ordinary shares of a par value of US$0.0001 each, (ii) 1,000,000 preference shares of a par value of US$0.0001 each, (iii) 199,950,000 Class A ordinary shares of a par value of US$0.0001 each, and the re -designationof 50,000 Class A ordinary shares of a par value of US$0.0001 each to 50,000 ordinary shares of a par value of US$1.00 each. 6Directors 6.1The names and addresses of the directors of the Surviving Company are:

| Name   |     | Address   |
| [Name] |     | [Address] |
| [Name] |     | [Address] |

6.2No director of the Surviving Company or the Merging Company has received or will receive any benefit consequent upon the Merger. 7Secured creditors Neither the Surviving Company